RALEIGH, N.C., Aug. 10, 2020 /PRNewswire/ — Today, HORIZON Labs Systems announced the deployment of version 13 of its laboratory information management system (LIMS), including an Oracle 19c technology upgrade and several new features, such as internationalization, database archiving and streamlined report delivery.
“HORIZON v13 enables greater performance and enhanced document security, while still being easy to upgrade,” said VP, Professional Services & Product Management, Kevin Carter. “Labs are now able to customize their user interface to stay aligned with industry-specific terminology and make use of date, phone and postal code formats required for Canadian laboratories.”
HORIZON LIMS version 13 features include:
Carter said HORIZON LIMS software upgrades are included in its annual maintenance fees. For questions regarding updates, contact client support at 919-855-8716, and select option 1.
For more information about HORIZON LIMS, visit horizonlims.com.
About HORIZON
Government and private labs rely on HORIZON LIMS to collect, process and test samples that impact millions of people – ensuring water and crop safety, disease readiness and management of other mission-critical health issues. With more than three decades of experience in the field, HORIZON’s technological advancements include its best-in-class Laboratory Information Management System (LIMS) helping to provide accurate results and insightful reporting in an efficient, effective and easy-to-use platform/interface. HORIZON is owned by Dohmen, and is one way Dohmen is fulfilling its preventive health mission, by keeping water, food and the environment safe. Visit www.horizonlims.com to learn more.
For More Information:
Carole Pfeil
Marketing Consultant
262 623 4054
Cpfeil@dohmen.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/horizon-announces-version-13-release-301109435.html
SOURCE HORIZON
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…